Establishment of a primary culture of patient-derived soft tissue sarcoma

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Soft tissue sarcomas (STS) represent a spectrum of heterogeneous malignancies with a difficult diagnosis, classification, and management. To date, more than 50 histological subtypes of these rare solid tumors have been identified. Thus, due to their extraordinary diversity and low incidence, our understanding of the biology of these tumors is still limited. Patient-derived cultures represent the ideal platform to study STS pathophysiology and pharmacology. We thus developed a human preclinical model of STS starting from tumor specimens harvested from patients undergoing surgical resection. Patient-derived STS cell cultures were obtained from the surgical specimens by collagenase digestion and isolated by filtration. Cells were counted, seeded, and left for 14 days in standard monolayer cultures and then processed by downstream analysis. Before performing molecular or pharmaceutical analyses, the establishment of STS primary cultures was confirmed through the evaluation of cytomorphologic features and, when available, immunohistochemical markers. This method represents a useful tool 1) to study the natural history of these poorly explored malignancies and 2) to test the effects of different drugs in an effort to learn more about their mechanisms of action.

Original languageEnglish
Article numbere56767
JournalJournal of Visualized Experiments
Volume2018
Issue number134
DOIs
Publication statusPublished - Apr 12 2018

Fingerprint

Sarcoma
Tissue
Tumors
Neoplasms
Tissue culture
Collagenases
Pharmaceutical Preparations
Drug products
Monolayers
Natural History
Digestion
Cell Culture Techniques
Pharmacology
Incidence

Keywords

  • Cancer research
  • Human preclinical model
  • In vitro
  • Issue 134
  • Patient-derived primary culture
  • Rare tumor
  • Soft tissue sarcoma
  • Surgical specimen

ASJC Scopus subject areas

  • Neuroscience(all)
  • Chemical Engineering(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

Establishment of a primary culture of patient-derived soft tissue sarcoma. / De Vita, Alessandro; Mercatali, Laura; Miserocchi, Giacomo; Liverani, Chiara; Spadazzi, Chiara; Recine, Federica; Bongiovanni, Alberto; Pieri, Federica; Cavaliere, Davide; Fausti, Valentina; Amadori, Dino; Ibrahim, Toni.

In: Journal of Visualized Experiments, Vol. 2018, No. 134, e56767, 12.04.2018.

Research output: Contribution to journalArticle

@article{a0ce10aca152468d8b2c006350519fcb,
title = "Establishment of a primary culture of patient-derived soft tissue sarcoma",
abstract = "Soft tissue sarcomas (STS) represent a spectrum of heterogeneous malignancies with a difficult diagnosis, classification, and management. To date, more than 50 histological subtypes of these rare solid tumors have been identified. Thus, due to their extraordinary diversity and low incidence, our understanding of the biology of these tumors is still limited. Patient-derived cultures represent the ideal platform to study STS pathophysiology and pharmacology. We thus developed a human preclinical model of STS starting from tumor specimens harvested from patients undergoing surgical resection. Patient-derived STS cell cultures were obtained from the surgical specimens by collagenase digestion and isolated by filtration. Cells were counted, seeded, and left for 14 days in standard monolayer cultures and then processed by downstream analysis. Before performing molecular or pharmaceutical analyses, the establishment of STS primary cultures was confirmed through the evaluation of cytomorphologic features and, when available, immunohistochemical markers. This method represents a useful tool 1) to study the natural history of these poorly explored malignancies and 2) to test the effects of different drugs in an effort to learn more about their mechanisms of action.",
keywords = "Cancer research, Human preclinical model, In vitro, Issue 134, Patient-derived primary culture, Rare tumor, Soft tissue sarcoma, Surgical specimen",
author = "{De Vita}, Alessandro and Laura Mercatali and Giacomo Miserocchi and Chiara Liverani and Chiara Spadazzi and Federica Recine and Alberto Bongiovanni and Federica Pieri and Davide Cavaliere and Valentina Fausti and Dino Amadori and Toni Ibrahim",
year = "2018",
month = "4",
day = "12",
doi = "10.3791/56767",
language = "English",
volume = "2018",
journal = "Journal of Visualized Experiments",
issn = "1940-087X",
publisher = "Journal of Visualized Experiments",
number = "134",

}

TY - JOUR

T1 - Establishment of a primary culture of patient-derived soft tissue sarcoma

AU - De Vita, Alessandro

AU - Mercatali, Laura

AU - Miserocchi, Giacomo

AU - Liverani, Chiara

AU - Spadazzi, Chiara

AU - Recine, Federica

AU - Bongiovanni, Alberto

AU - Pieri, Federica

AU - Cavaliere, Davide

AU - Fausti, Valentina

AU - Amadori, Dino

AU - Ibrahim, Toni

PY - 2018/4/12

Y1 - 2018/4/12

N2 - Soft tissue sarcomas (STS) represent a spectrum of heterogeneous malignancies with a difficult diagnosis, classification, and management. To date, more than 50 histological subtypes of these rare solid tumors have been identified. Thus, due to their extraordinary diversity and low incidence, our understanding of the biology of these tumors is still limited. Patient-derived cultures represent the ideal platform to study STS pathophysiology and pharmacology. We thus developed a human preclinical model of STS starting from tumor specimens harvested from patients undergoing surgical resection. Patient-derived STS cell cultures were obtained from the surgical specimens by collagenase digestion and isolated by filtration. Cells were counted, seeded, and left for 14 days in standard monolayer cultures and then processed by downstream analysis. Before performing molecular or pharmaceutical analyses, the establishment of STS primary cultures was confirmed through the evaluation of cytomorphologic features and, when available, immunohistochemical markers. This method represents a useful tool 1) to study the natural history of these poorly explored malignancies and 2) to test the effects of different drugs in an effort to learn more about their mechanisms of action.

AB - Soft tissue sarcomas (STS) represent a spectrum of heterogeneous malignancies with a difficult diagnosis, classification, and management. To date, more than 50 histological subtypes of these rare solid tumors have been identified. Thus, due to their extraordinary diversity and low incidence, our understanding of the biology of these tumors is still limited. Patient-derived cultures represent the ideal platform to study STS pathophysiology and pharmacology. We thus developed a human preclinical model of STS starting from tumor specimens harvested from patients undergoing surgical resection. Patient-derived STS cell cultures were obtained from the surgical specimens by collagenase digestion and isolated by filtration. Cells were counted, seeded, and left for 14 days in standard monolayer cultures and then processed by downstream analysis. Before performing molecular or pharmaceutical analyses, the establishment of STS primary cultures was confirmed through the evaluation of cytomorphologic features and, when available, immunohistochemical markers. This method represents a useful tool 1) to study the natural history of these poorly explored malignancies and 2) to test the effects of different drugs in an effort to learn more about their mechanisms of action.

KW - Cancer research

KW - Human preclinical model

KW - In vitro

KW - Issue 134

KW - Patient-derived primary culture

KW - Rare tumor

KW - Soft tissue sarcoma

KW - Surgical specimen

UR - http://www.scopus.com/inward/record.url?scp=85045525533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045525533&partnerID=8YFLogxK

U2 - 10.3791/56767

DO - 10.3791/56767

M3 - Article

C2 - 29708525

AN - SCOPUS:85045525533

VL - 2018

JO - Journal of Visualized Experiments

JF - Journal of Visualized Experiments

SN - 1940-087X

IS - 134

M1 - e56767

ER -